resveratrol has been researched along with Bone Loss, Perimenopausal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuo, ML; Su, JL; Yang, CY; Yen, ML; Zhao, M | 1 |
| Cannavo, A; Conti, V; Corbi, G; Davinelli, S; Medoro, A; Nobile, V; Scapagnini, G; Sorrenti, V | 1 |
| Baby, C; Chourasia, MK; Ghate, V; Lewis, S; Narayana Kalkura, S; Nayak, Y; Saklani, R; Shah, A; Shah, AA; Singh, PK | 1 |
| Ambati, S; Baile, CA; Bass, EF; Della-Fera, MA; Hartzell, DL; Hohos, NM; Kelso, EW; Miller, CN; Rayalam, S; Trunnell, ER; Yang, JY | 1 |
| Li, J; Li, N; Li, X; Li, Z; Liu, J; Liu, T; Xiao, H; Zhao, H | 1 |
| Parazzini, F | 1 |
| Cao, P; Feng, J; Lei, W; Liu, S; Ma, S; Qi, W; Wang, Z; Zhang, W; Zhao, J | 1 |
| Huber, J | 1 |
2 review(s) available for resveratrol and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause.
Topics: Animals; Cardiovascular Diseases; Cell Line; Female; Humans; Inositol; Mice; Osteoporosis, Postmenopausal; Perimenopause; Postmenopause; Resveratrol; Risk Factors; Stilbenes; Vitamin D; Vitamin K | 2014 |
[Phytoestrogens and SERMS, alternatives to classical hormone therapy?].
Topics: Aged; Anticarcinogenic Agents; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Genistein; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Postmenopause; Receptors, Estrogen; Resveratrol; Selective Estrogen Receptor Modulators; Stilbenes | 2000 |
1 trial(s) available for resveratrol and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.
Topics: Alkaline Phosphatase; Biomarkers; Bone Density; Bone Remodeling; Equol; Female; Humans; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Resveratrol; Tartrate-Resistant Acid Phosphatase | 2023 |
5 other study(ies) available for resveratrol and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Breast Neoplasms; Cell Line, Tumor; Estrogen Replacement Therapy; Estrogens; Female; Forkhead Transcription Factors; Gene Expression Regulation, Enzymologic; Humans; Mice; Osteoporosis, Postmenopausal; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Resveratrol; Risk Factors; src-Family Kinases; Stilbenes; Transforming Growth Factor beta | 2007 |
Cyclodextrin based bone regenerative inclusion complex for resveratrol in postmenopausal osteoporosis.
Topics: Animals; Anti-Inflammatory Agents; beta-Cyclodextrins; Biological Availability; Disease Models, Animal; Excipients; Female; Humans; Molecular Docking Simulation; Osteoporosis, Postmenopausal; Rats; Rats, Wistar; Resveratrol; Solubility; X-Ray Microtomography | 2021 |
Synergistic Phytochemicals Fail to Protect Against Ovariectomy Induced Bone Loss in Rats.
Topics: Adiposity; Animals; Bone Density; Drug Synergism; Drug Therapy, Combination; Female; Genistein; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Phytochemicals; Quercetin; Rats; Rats, Inbred F344; Resveratrol | 2018 |
Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus.
Topics: Animals; Antioxidants; Biomarkers; Bone Density; Bone Density Conservation Agents; Dietary Supplements; Disease Models, Animal; Endometrial Hyperplasia; Endometrium; Estrogen Replacement Therapy; Female; Femur; Humans; Osteoporosis, Postmenopausal; Osteoprotegerin; Phytoestrogens; Random Allocation; RANK Ligand; Rats; Rats, Wistar; Resveratrol; Stilbenes; Time Factors | 2014 |
Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway.
Topics: Animals; Base Sequence; Bone Density; Cell Differentiation; DNA Primers; Female; Humans; Middle Aged; NF-kappa B; Osteoblasts; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; X-Ray Microtomography | 2014 |